BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 19631793)

  • 1. The management of failed second-trimester termination of pregnancy.
    Basu JK; Basu D
    Contraception; 2009 Aug; 80(2):170-3. PubMed ID: 19631793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of vaginal misoprostol for second-trimester pregnancy termination in women with previous single cesarean section.
    Daponte A; Nzewenga G; Dimopoulos KD; Guidozzi F
    Contraception; 2006 Oct; 74(4):324-7. PubMed ID: 16982234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy termination using vaginal misoprostol in women with more than one caesarean section.
    Daponte A; Nzewenga G; Dimopoulos KD; Guidozzi F
    J Obstet Gynaecol; 2007 Aug; 27(6):597-600. PubMed ID: 17896259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a single misoprostol regimen in the first and second trimester termination of pregnancy.
    van Bogaert LJ; Sedibe TM
    J Obstet Gynaecol; 2007 Jul; 27(5):510-2. PubMed ID: 17701803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misoprostol for second trimester pregnancy termination in women with prior caesarean section.
    Daskalakis GJ; Mesogitis SA; Papantoniou NE; Moulopoulos GG; Papapanagiotou AA; Antsaklis AJ
    BJOG; 2005 Jan; 112(1):97-9. PubMed ID: 15663405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic termination of second trimester pregnancies with low dose misoprostol.
    Liaquat NF; Javed I; Shuja S; Shoaib T; Bano K; Waheed S; Ansar A
    J Coll Physicians Surg Pak; 2006 Jul; 16(7):464-7. PubMed ID: 16827957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-trimester pregnancy termination with 600-microg vs. 400-microg vaginal misoprostol and systematic curettage postexpulsion: a randomized trial.
    Carbonell JL; Torres MA; Reyes R; Ortega L; García-Gallego F; Sánchez C
    Contraception; 2008 Jan; 77(1):50-5. PubMed ID: 18082667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study].
    Verhulsdonk MT; Papatsonis DN; Heydanus R
    Ned Tijdschr Geneeskd; 2007 Apr; 151(14):815-20. PubMed ID: 17469323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mifepristone- and misoprostol-induced mid-trimester termination of pregnancy: a review of 272 cases.
    Rose SB; Shand C; Simmons A
    Aust N Z J Obstet Gynaecol; 2006 Dec; 46(6):479-85. PubMed ID: 17116051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Success rate of second-trimester termination of pregnancy using misoprostol.
    Prachasilpchai N; Russameecharoen K; Borriboonhirunsarn D
    J Med Assoc Thai; 2006 Aug; 89(8):1115-9. PubMed ID: 17048418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to manage unresponsiveness to misoprostol in failed second trimester pregnancy termination.
    Pongsatha S; Tongsong T
    J Obstet Gynaecol Res; 2013 Jan; 39(1):154-9. PubMed ID: 22691227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-trimester pregnancy interruption with vaginal misoprostol in women with previous cesarean section.
    Pongsatha S; Tongsong T
    J Med Assoc Thai; 2006 Aug; 89(8):1097-100. PubMed ID: 17048415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management.
    Gemzell-Danielsson K; Lalitkumar S
    Reprod Health Matters; 2008 May; 16(31 Suppl):162-72. PubMed ID: 18772097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of gestational age on the outcome of second-trimester termination of pregnancies for foetal abnormalities.
    Lo TK; Lau WL; Lai FK; Lam H; Tse HY; Leung WC; Chin RK
    Prenat Diagn; 2008 Jun; 28(6):508-11. PubMed ID: 18509869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of dilation and evacuation versus the induction of labor for second-trimester pregnancy termination.
    Cowett AA; Golub RM; Grobman WA
    Am J Obstet Gynecol; 2006 Mar; 194(3):768-73. PubMed ID: 16522411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized comparison of misoprostol to intrauterine instillation of hypertonic saline plus a prostaglandin F2alpha analogue for second-trimester induction termination in Uzbekistan.
    Kapp N; Todd CS; Yadgarova KT; Alibayeva G; Nazarova D; Loza O; Babadjanova GS
    Contraception; 2007 Dec; 76(6):461-6. PubMed ID: 18061705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced second trimester abortion by extra-amniotic prostaglandin infusion in patients with a cesarean scar: is it safe?
    Shapira S; Goldberger S; Beyth Y; Fejgin MD
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):511-4. PubMed ID: 10376860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of second-trimester pregnancy terminations with misoprostol: comparing 2 regimens.
    Edwards RK; Sims SM
    Am J Obstet Gynecol; 2005 Aug; 193(2):544-8; author reply 548-50. PubMed ID: 16098889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misoprostol-induced termination of second-trimester pregnancy in women with a history of cesarean section: a retrospective analysis of 56 cases.
    Turgut A; Ozler A; Görük NY; Karaçor T; Yalinkaya A
    Ginekol Pol; 2013 Apr; 84(4):277-80. PubMed ID: 23700860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is induced abortion with misoprostol a risk factor for late abortion or preterm delivery in subsequent pregnancies?
    Winer N; Resche-Rigon M; Morin C; Ville Y; Rozenberg P
    Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):53-6. PubMed ID: 19427095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.